US 9120813
Oxadiazoanthracene compounds for the treatment of diabetes
granted A61PA61P1/12A61P1/16
Quick answer
US patent 9120813 (Oxadiazoanthracene compounds for the treatment of diabetes) held by VTV THERAPEUTICS LLC expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VTV THERAPEUTICS LLC
- Grant date
- Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/12, A61P1/16, A61P13/12, A61P25/02